APA (7th ed.) Citation

B, G., B, M., A, N., F, D., G, K., A, G., . . . G, V. (2009). Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium. European journal of cancer (Oxford, England : 1990), 45(13), 2342. https://doi.org/10.1016/j.ejca.2009.03.007

Chicago Style (17th ed.) Citation

B, Geoerger, et al. "Target-driven Exploratory Study of Imatinib Mesylate in Children with Solid Malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium." European Journal of Cancer (Oxford, England : 1990) 45, no. 13 (2009): 2342. https://doi.org/10.1016/j.ejca.2009.03.007.

MLA (9th ed.) Citation

B, Geoerger, et al. "Target-driven Exploratory Study of Imatinib Mesylate in Children with Solid Malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium." European Journal of Cancer (Oxford, England : 1990), vol. 45, no. 13, 2009, p. 2342, https://doi.org/10.1016/j.ejca.2009.03.007.